High rates of regimen change due to drug toxicity among a cohort of South Indian adults with HIV infection initiated on generic, first-line antiretroviral treatment

Journal of Association of Physicians of India

Volumn 57, Issue 5, 2009, Pages 384-388

  Sivadasan, Ajith ^a   Abraham, O C ^a   Rupali, Priscilla ^a   Pulimood, Susanne A ^a   Rajan, Joyce ^a   Rajkumar, S ^a   Zachariah, Anand ^a   Kannangai, Rajesh ^a   Kandathil, Abraham Joseph ^a   Sridharan, G ^a   Mathai, Dilip ^a  

^a CHRISTIAN MEDICAL COLLEGE   (India)

Author keywords

[No Author keywords available]

Indexed keywords

ANTI HUMAN IMMUNODEFICIENCY VIRUS AGENT; ANTIRETROVIRUS AGENT; GENERIC DRUG; RNA DIRECTED DNA POLYMERASE INHIBITOR;

ADULT; ARTICLE; CD4 LYMPHOCYTE COUNT; COHORT ANALYSIS; CONFIDENCE INTERVAL; DISEASE COURSE; FEMALE; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; INCIDENCE; INDIA; MALE; MORTALITY; PATIENT COMPLIANCE; PROSPECTIVE STUDY; RISK; STATISTICAL MODEL; STATISTICS; T LYMPHOCYTE; HIV INFECTIONS; MEDICATION COMPLIANCE; STATISTICS AND NUMERICAL DATA;

ADULT; ANTI-HIV AGENTS; ANTI-RETROVIRAL AGENTS; CD4 LYMPHOCYTE COUNT; COHORT STUDIES; CONFIDENCE INTERVALS; DISEASE PROGRESSION; DRUGS, GENERIC; FEMALE; HIV INFECTIONS; HUMANS; INCIDENCE; INDIA; LOGISTIC MODELS; MALE; MEDICATION ADHERENCE; ODDS RATIO; PROSPECTIVE STUDIES; REVERSE TRANSCRIPTASE INHIBITORS; T-LYMPHOCYTES;

EID: 70349636040     PISSN: 00045772     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (10)

1. Joint United Nations Programme on HIV/AIDS (UNAIDS). AIDS epidemic update: December 2007. Geneva: WHO; 2007. Available from: http://www.unaids.org/en/KnowledgeCentre/HIVData/EpiUpdate/EpiUpdArchive/2007/default.asp.
2. Gilks CF, Crowley S, Ekpini R, Gove S, Perriens J, Souteyrand Y, et al. The WHO public-health approach to antiretroviral treatment against HIV in resource-limited settings. Lancet 2006;368(9534):505-10.
3. World Health Organization. Antiretroviral therapy for HIV infection in adults and adolescents in resource-limited settings: towards universal access: recommendations for a public health approach (2006 revision). Geneva: WHO; 2006. Available from: http://www.who.int/hiv/pub/guidelines/artadultguidelines.pdf.
4. National AIDS Control Organization. Antiretroviral Therapy Guidelines for HIV-infected Adults and Adolescents Including Postexposure Prophylaxis. New Delhi: Ministry of Health and Family Welfare, Government of India; 29/08/2007. Available from: http://www.nacoonline.org/upload/Publication/Treatment%20Care%20and%20support/Antiretroviral%20Therapy%20Guidelines%20for%20HIV-Infected%20Adults%20and%20Adolescents%20Including%20Post-exposure.pdf
5. Pujari SN, Patel AK, Naik E, Patel KK, Dravid A, Patel JK, et al. Effectiveness of generic fixed-dose combinations of highly active antiretroviral therapy for treatment of HIV infection in India. J Acquir Immune Defic Syndr 2004;37:1566-9.
6. Sungkanuparph S, Manosuthi W, Kiertiburanakul S, Piyavong B, Chumpathat N, Chantratita W. Options for a second-line antiretroviral regimen for HIV type 1-infected patients whose initial regimen of a fixed-dose combination of stavudine, lamivudine, and nevirapine fails. Clin Infect Dis 2007;44:447-52.
7. Hammer SM, Saag MS, Schechter M, Montaner JS, Schooley RT, Jacobsen DM, et al. Treatment for adult HIV infection: 2006 recommendations of the International AIDS Society-USA panel. JAMA 2006;296:827-43.
8. Kumarasamy N, Vallabhaneni S, Cecelia AJ, Yepthomi T, Balakrishnan P, Saghayam S, et al. Reasons for modification of generic highly active antiretroviral therapeutic regimens among patients in southern India. J Acquir Immune Defic Syndr 2006;41:53-8.
9. Srasuebkul P, Calmy A, Zhou J, Kumarasamy N, Law M, Lim PL. Impact of drug classes and treatment availability on the rate of antiretroviral treatment change in the TREAT Asia HIV Observational Database (TAHOD). AIDS Res Ther 2007;4:18.
10. Rajasekaran S, Jeyaseelan L, Vijila S, Gomathi C, Raja K. Predictors of failure of first-line antiretroviral therapy in HIV-infected adults: Indian experience. AIDS 2007;21 Suppl 4:S47-S53.